Additional file 3 of How do you manage ANTICOagulant therapy in neurosurgery? The ANTICO survey of the Italian Society of Neurosurgery (SINCH)
Additional file 3: Supplementary Fig. 3. QUESTIONS 8, 9 and 10: In your opinion, what is the optimal timing for anti-thrombotic therapy resumption in patients at high thrombotic risk (e.g. valvular atrial fibrillation, ventricular devices), moderate thrombotic risk (e.g. non-valvular atrial fibrilla...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Bild |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Additional file 3: Supplementary Fig. 3. QUESTIONS 8, 9 and 10: In your opinion, what is the optimal timing for anti-thrombotic therapy resumption in patients at high thrombotic risk (e.g. valvular atrial fibrillation, ventricular devices), moderate thrombotic risk (e.g. non-valvular atrial fibrillation) and low-thrombotic risk (e.g. previous history of deep venous thrombosis)? |
---|---|
DOI: | 10.6084/m9.figshare.14157726 |